Trending:
Comment
-
25 April 2018
World Malaria Day 2018: to achieve eradication, malaria transmission must be stopped
On 25 April, the World Health Organization (WHO) member states celebrate World Malaria Day. This year’s theme, ‘Ready to Beat Malaria’, highlights the collective goal of the global malaria community...
-
25 April 2018
The late-stage type 2 diabetes pipeline is dominated by ‘me-too’ drugs
Type 2 diabetes (T2D) is a chronic disease characterised by insulin resistance and pancreatic β-cell failure, with an underlying genetic predisposition that is heavily influenced by diet and lifestyle.
-
25 April 2018
Hemlibra receives FDA breakthrough therapy designation
On 17 April, Roche announced that the US FDA had granted breakthrough therapy designation to Hemlibra, for patients with haemophilia A without factor VIII inhibitors.
-
24 April 2018
Ketamine may become a key therapy in the treatment of depression
Yale University has found that a single dose of nasal spray ketamine (esketamine) reduces acute symptoms of depression (at 4 and 24 hours) and suicidal thoughts in patients with an...
-
24 April 2018
The state of US somatic cell therapy facilities
The US had the largest pharmaceutical market revenue in 2017, and is expected to continue to do so for the foreseeable future.
-
24 April 2018
New therapy set to dominate the HIV market
Gilead Sciences’ new HIV therapeutic Biktarvy has recently gained approval, and is expected to have a major impact on the market.
-
24 April 2018
Tremfya approval: increasing options for psoriasis treatment
Johnson & Johnson’s (J&J) Tremfya (guselkumab) has recently been granted approval for the treatment of adults suffering from moderate-to-severe plaque psoriasis in Australia, Brazil, and Japan. J&J has licensed Tremfya...
-
24 April 2018
Blockbuster immunology drugs facing patent expiry and biosimilar competition
Despite the highly competitive nature of the immunology drugs market there are several well-established blockbuster drugs that dominate in terms of revenue.
-
23 April 2018
Experts call for a review of pharma manufacturing processes
Industry experts called for a rethink of pharma industry paradigms around manufacturing orphan and cell products at DCAT Week 2018, which took place in New York City last month.
-
23 April 2018
Pfizer funds CreakyJoints’ initiative for shared decision making in rheumatoid arthritis
In a landmark moment for rheumatoid arthritis (RA) treatment, Pfizer has joined forces with CreakyJoints, an online patient advocacy group, in an initiative to improve shared decision making about treatment...
